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Early stage adenoid cystic carcinoma of the posterior nasal septum:  
a rare manifestation
Asmaa Kouadir1, Khalid Hassouni1, 2
Adenoid cystic carcinomas are rare malignant tumors that commonly arise from major and minor salivary glands and 
are characterized by slow growth, frequent local recurrences, and high incidence of distant metastasis, especially 
reported in patients with advanced stage tumors. Adenoid cystic carcinomas can rarely occur in other areas of the 
head and neck region, notably in the nasal cavity. Moreover, adenoid cystic carcinoma limited to the nasal septum 
is particularly unusual and has been the subject of a small number of published cases only. We discuss here a case 
of a 42 year-old woman diagnosed with early stage adenoid cystic carcinoma of the posterior nasal septum, treated 
solely with surgical resection via endoscopic approach. During five years of follow-up, no local recurrence or distant 
metastasis has been detected.
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Introduction
Adenoid cystic carcinomas (ACC), first described by Ro-
bin and Laboulbene in 1853, are rare and account for less 
than 1% of all head and neck malignancies. They commonly 
arise within salivary glands and are characterized by slow 
growth, low probability of lymphatic spread, frequent local 
recurrences, and high incidence of distant metastasis (DM), 
which is even reported in patients with early stage tumors 
[1–3]. In the sinonasal tract, ACC accounts for 10–25% of all 
head and neck ACCs [4]. However, in the nasal septum this 
tumor is exceedingly rare. Actually, to date only few cases 
of ACC arising from the nasal septum have been reported 
in the literature [5]. Here we discuss a new case of unusual 
presentation of ACC of the nasal septum. 
Case report
A 42 year-old Moroccan married woman with no past 
personal history of disease or surgery and non-contributory 
family history, showed up at the Ear, Nose, & Throat (ENT) 
department with a complaint of occasional epistaxis asso-
ciated with nasal obstruction, over one year period. Nasal 
endoscopy revealed well defined, polypoid mass in the 
posterior part of the left side of nasal cavity. Neck clinical 
examination revealed no abnormalities of cervical lymph 
nodes. 
A biopsy of the lesion was performed and fragmented 
tissue biopsies were histologically investigated. Histopatho-
logical examination revealed a tumor proliferation compo-
sed of a double contingent of malignant cells. Actually, it 
was composed of epithelial and myoepithelial cells with mo-
derate cytonuclear atypia and hyperchromatic nuclei, and 
clear cytoplasm. Tumor cells were arranged in tubular and 
cribriform architectural patterns (Fig. 1). The tubular lumens 
were filled with mucoid material. All these structures were 
supported by a thin fibrous stroma. In immunochemistry, 
myoepithelial cells expressed Smooth Muscle Actin (SMA) 
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(Fig. 2), whereas epithelial cells were positively immuno-
stained for c-Kit (CD117) (Fig. 3). Based on these data, the 
diagnosis of ACC has been established. 
Computed tomography (CT) of the paranasal sinuses 
(PNS) subsequently performed, confirmed the findings of 
a 17.1 × 13.8 mm soft tissue mass arising from the poste-
Figure 1. Picture showing adenoid cystic carcinoma exhibiting cribriform and tubular patterns (Hematoxylineosin staining × 200)
Figure 2. In immunohistochemistry, Adenoid cystic carcinoma showed an immunostaining with antibodies against smooth muscle actin (× 400)
Figure 3. Adenoid cystic carcinoma showed an immunostaining with antibodies against CD117 (× 400)
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rior part of the nasal septum with no sign of locoregional 
invasion (Fig. 4). Computed tomography CT scan of the 
neck showed no lymph node involvement. The results of 
metastatic workup, including chest X-ray and abdominal 
ultrasound exam were negative. Thus, the tumor was clas-
sified as T1N0M0 corresponding to stage I of the staging of 
carcinoma of the nasal cavity, ethmoid and maxillary sinus 
according to the 7th edition of the American Joint Commit-
tee on Cancer (AJCC) Cancer Staging Manual.
The patient underwent an endoscopic resection which 
removed the tumor en-bloc along with adjacent bony sep-
tum and a cuff of cartilaginous septum. The surgery and 
the early post-operative period were uneventful. Histopa-
thological examination of the operative specimen showed 
an ACC infiltrating the adjacent bone, whereas the cartilage 
was found free of tumor. On the other hand, there was no 
perineural invasion and negative surgical margins were 
confirmed.
The case was discussed at multidisciplinary consultation 
meeting (RCP), and the RCP decision was to initiate adjuvant 
radiotherapy. Unfortunately, the patient has been lost sight 
of for nine months after surgery. When she showed up at our 
department, new clinical and radiological examinations (CT 
scans) were performed and showed no evidence of recur-
rence (Fig. 5). After discussion between radiation therapists, 
adjuvant radiotherapy was deemed to be non-beneficial 
after nine months from surgery. Thus, no adjuvant therapy 
was performed and the patient was kept on a close follow-
-up schedule, with clinical examinations every three months, 
and CT scans of the PNS and the neck as well as the chest and 
the abdomen CT scans every year. Five years after surgery, 
the patient is still disease-free.
Discussion
The incidence of malignant tumors of the nasal septum 
is very low, comprising 2.7–8.4% of nasal and paranasal 
malignant tumors [5]. Although ACC is the second most 
common cancer occurring in the sinonasal tract and usually 
invades the lateral wall of the nose, its location in the nasal 
septum remains exceedingly scarce, as it has been shown 
in two older clinical reports. Actually, among 43 malignant 
tumors of the nasal septum included in Young study, there 
has been only one case of ACC. The same remark was re-
ported in Beatty et al. study, where one single case of ACC 
was found amongst 85 nasal septum carcinomas [6–9]. 
Furthermore, very few cases of ACC of the posterior nasal 
septum are encountered in the literature [7, 10, 11]. 
According to a recent meta-analysis, the median age of 
patients with ACC of the nasal cavity and paranasal sinuses 
was 50 years (range, 38 to 55 years) with slight predomi-
nance in females [12]. Due to the rarity of these tumors, 
there is little data on whether specific ethnic, geographic, 
exposure, or other factors predispose to the development 
of the disease [13].
Figure 4. Axial (A) and frontal (B) CT images showing a soft-tissue mass arising from the posterior part of the left side of nasal septum (white arrow)
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The most common presentation of ACC is an asymp-
tomatic slowly enlarging mass, often in the head and neck 
area [13]. However, ACC of the nasal cavity may manifest 
through obstruction, epistaxis, discharge and facial swelling 
[5, 7, 10]. Pain or paresthesia may also be reported and likely 
reflect the tumor’s propensity for perineural infiltration [13]. 
Although advanced ACC arising from the sinonasal tract is 
believed to be common at initial evaluation, early detection 
of nasal septum ACC may be possible because symptoms 
may appear early in the disease [7], such was the case with 
our patient.
Regarding diagnostic imaging techniques, both imaging 
modalities (CT and MRI) are very valuable for evaluation 
of the tumor features as well as its extension. In fact, low 
grade ACC of the sinonasal tract may mimic the features of 
a simple polyp filling the nasal cavity and slightly remode-
ling the bones at both CT and MR imaging, whereas high 
grade ACC may manifest as a large irregular mass with bone 
destruction and irregular density and signal at both CT 
and MR imaging. Moreover, ACC is also well known for its 
predisposition to perineural spread along the cranial nerves 
that can extend into the skull base. Hence, MR imaging with 
intravenous contrast injection is mandatory, in order to map 
this perineural spread. On the other hand, the value of [18F] 
FDG-PET/CT in ACC is limited due to low metabolic activity 
and therefore low FDG uptake [14].
Histologically, ACCs exhibit varying proportions of three 
distinct growth patterns that are referred to as cribriform, 
tubular, and solid [13]. These tumors can be graded histolo-
gically according to Szanto et al. into three grades, based on 
the proportion of solid pattern: Grade 1 where solid pattern 
= 0%, Grade 2 where solid pattern < 30% and Grade 3 where 
solid pattern > 30% [15]. Patients with solid type ACC have 
the worst prognosis [7,13]. The cribriform pattern is the most 
common histologic subtype and all septal ACC previously 
reported was the cribriform pattern [5, 7, 10, 11]. In our 
case, only cribriform and tubular patterns were exhibited, 
thus the case was classified as grade 1 ACC. Furthermore, 
immunohistochemistry remains often necessary for ACC 
diagnosis. In fact, myoepithelial tumor cells that surround 
the pseudocysts stain positively for smooth muscle actin 
(SMA), S100, vimentin, and smooth muscle myosin heavy 
chain. Also, ACC cells are strongly positive for the receptor 
tyrosine kinase c-KIT (CD117) and myeloblastosis oncogene 
(MYB) regardless of grade [13].
In terms of treatment, ACC of the nasal cavity and pa-
ranasal sinuses poses numerous treatment challenges for 
many reasons, inter alia, its high propensity for local inva-
sion to adjacent structures, making resection more difficult. 
However, surgery remains the mainstay of treatment of 
these tumors [12]. Recently, some authors deem that sur-
gical resection of ACC of the sinonasal tract via endoscopic 
approach could be an effective mini-invasive method that 
Figure 5. Axial (A) and frontal (B) images from PNS CT scan performed 9 months after surgery showing no evidence of recurrence
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in well-selected patients could be satisfactorily applied, 
together with adjuvant therapies, giving good results, com-
plete removal of a tumor and high surviving rate [3]. On the 
other hand, ACC is considered to be a radiosensitive but not 
radio-curable tumor. Hence, postoperative radiation therapy 
aims to treat residual microscopic disease, which is present 
in most patients [7]. Nevertheless, data obtained from the US 
National Cancer Institute’s Surveillance, Epidemiology, and 
End Results (SEER) program by Ellington et al. show little to 
no clear benefit of adjuvant radiotherapy for ACC of head 
and neck [2]. Moreover, many ACC tumors do not benefit 
from systemic chemotherapy, as they have slow growth 
kinetics. However, several chemotherapy studies have been 
performed over the years. The results show consistently low 
response rates to cytotoxic chemotherapy for metastatic 
disease. Thus, to date, there is no accepted standard syste-
mic chemotherapy for patients with ACC tumors. Regarding 
targeted therapies, the elucidation of the genetic basis of 
ACCs has identified novel candidate therapeutic targets 
inter alia, the MYB oncoprotein which is the most promising. 
However, targeted agents are early in development for ACC 
and care should be taken when using them off-trial [13]. 
Due to its rarity, there is some controversy over the 
clinical and histological factors that affect the survival of 
patients with ACC of the sinonasal tract. If the impact of the 
type and grade of tumor on survival is agreed by all authors, 
perineural invasion, efficacy of adjuvant treatment, and the 
site of origin were found to be significant prognostic factors 
by some authors, whereas others found that they had no 
impact on survival [2, 12, 13]. Actually, a recent meta-analysis 
of Amit et al. revealed that margin status and tumor site were 
significant predictors of outcome in patients with ACC of 
the nasal cavity and paranasal sinuses, whereas perineural 
invasion was not associated with prognosis. In addition, no 
added benefit of adjuvant treatment has been noticed [12].
Finally, due to the possibility of delayed recurrences and 
DM, long-term surveillance is currently required for patients 
with ACC [1, 2, 13].
Conclusion
Adenoid cystic carcinomas of the nasal cavity are a rare 
clinical entity which continues to pose diagnostic and the-
rapeutic challenges to physicians. They usually involve the 
lateral wall of the nose. Their involvement of the posterior 
nasal septum is extremely rare. Despite their rarity, they sho-
uld be taken into consideration in the differential diagnosis 
of a nasal tumor. Moreover, the most effective treatment 
modality and prognosis risk factors of these tumors are still 
under debate. Delayed recurrences and DM require long-
-term follow-up for patients with such tumors.
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